Manns Medium

Leave it to the media to title an article but never present the other side of the coin.  What’s the other side of the coin you ask?  Just how much is enough for the price of a human liver and just how many people must die before the cost and idea of making millions are replaced by the desire to do good?  The article is written by Ricardo Alonso-Zaldivar and it is titled “$1,000-per-pill drug overtaken by pricier successor ” for the Associated Press.  In the article it details a whole host of things like “ the $1,000 pill for a liver-wasting viral infection that made headlines last year is no longer the favorite of patients and doctors.  The new leading pill for hepatitis C is more expensive, and the number of patients seeking a cure has surged.  Sovaldi, last year's wonder drug, has been pushed aside by a successor called Harvoni, made by the same company. The sticker price for Harvoni is $1,350 a pill. ”  Noticed that the same company improved their ...

My wife stumbled upon this article titled “Few vets getting care through $10 billion VA program” written by David Caruso for the Associated Press and shared it with me.  After reading it, I became abundantly aware of how misguided some programs can become especially when they appear to be administered by people who have no earthly idea to whom they are attempting to service.  They seem to lack the understanding of the particular kind of citizen to who they are contacting and quickly lose focus behind the initial reasoning for the program in the first place. As reported “a new program that was supposed to get patients off waiting lists at Veterans Affairs medical centers by letting them switch to private-sector doctors is proving to be an even bigger disappointment than initially thought.  The Veteran's Choice program launched on Nov. 5 with $10 billion in funding and the expectation that it would instantly relieve backlogs at VA hospitals and clinics. But after a hur...